Findings from Eisai Co. Ltd. Reveals New Findings on Alzheimer Disease [Population Pharmacokinetics and Exposure-response Analyses of Safety (Aria-e and Isolated Aria-h) of Lecanemab In Subjects With Early Alzheimer's Disease]

Source :: Obesity, Fitness & Wellness Week. September 28, 2024, 66
Publication Year :: 2024
Abstract: 2024 SEP 28 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Neurodegenerative Diseases and Conditions - Alzheimer Disease. [...]

Subjects :: Eisai Company Ltd. -- Safety and security measures
Medical research -- Safety and security measures
Medicine, Experimental -- Safety and security measures
Diseases -- Research -- Drug therapy -- Japan -- United Kingdom
Alzheimer's disease -- Research -- Drug therapy
Physical fitness -- Research -- Safety and security measures
Pharmaceutical industry -- Safety and security measures -- Research
Health

Tools